Sartorius Stedim Biotech launches Integrated Solutions online resource center
New website will support clients in developing and implementing entire single-use bioprocesses.
Sartorius Stedim Biotech has launched its Integrated Solutions website, an online resource and information centre to support its clients as they develop and implement entire single-use or hybrid biomanufacturing processes.
The new website is designed to assist clients in the implementation of flexible, scalable and cost-efficient bioprocesses by utilizing the tools, technologies, support and expertise available from Sartorius Stedim Biotech. To allow clients to better understand the effectiveness with which Integrated Solutions can be applied to their bioprocesses a comprehensive portfolio of case studies are available from companies such as Boehringer Ingelheim, Wuxi AppTec, Mabion, DMBio and Bayer.
The biopharmaceutical industry is being forced to adapt to changing and challenging market conditions. Reducing costs and increasing process optimization are becoming increasingly important due to pressures from healthcare providers and competition from biosimilars. Sartorius Stedim Biotech’s new Integrated Solutions website describes how the company addresses these challenges through partnering with clients to design and develop entire single-use and hybrid processes for the manufacture of biopharmaceuticals. Process development activities are coordinated by a team of process development consultants utilizing an array of technologies and software tools while the design and engineering of the large-scale bioprocess is performed by a separate, dedicated team that have successfully completed over 100 fully single-use projects.
Ensuring clients benefit from the shortest time to market, Sartorius Stedim Biotech is using the Integrated Solutions website to showcase its new ‘mAb Process Platform’. The new platform is a result of the company’s innovative ‘Process4Success’ initiative which seeks to leverage both novel single-use processing technologies and the expertise within the organization to define sequences of unit operations that can be combined to create an entire bioprocess line.
Multiple client testimonials are available on the new resource center describing how the Integrated Solutions approach has already been successfully applied to a number of diverse collaborative projects. For example, speaking of a recent collaboration between Sartorius Stedim Biotech and Boehringer Ingelheim, Jan Feuser (Head of Clinical Supply Facility Downstream at Boehringer Ingelheim) said: “The ability to work across different sites at a global scale with one Boehringer Ingelheim project team and one Sartorius project team, truly enabled the success of the project.“
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance